Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 14:3:100068.
doi: 10.1016/j.prdoa.2020.100068. eCollection 2020.

Levodopa-induced belly dancer's dyskinesia: Case report

José Renan Miranda Cavalcante-Filho  1 , Walterney Amâncio-Filho  2 , Bruno Gonzales Miniello  2
Affiliations
Case Reports

Levodopa-induced belly dancer's dyskinesia: Case report

José Renan Miranda Cavalcante-Filho et al. Clin Park Relat Disord. .

Abstract

The first report of an abdominal wall dyskinesia syndrome was published in 1990 by Iliceto et al. (1990), who were the first to use the "belly dancer dyskinesia" (BDD) nomenclature. BDD is a rare syndrome involving repetitive, involuntary, and continuous movements of the abdominal wall muscles (Iliceto et al., 1990). We describe the case of a 79-year-old, right-handed woman who showed symptoms of BDD syndrome after using levodopa due to parkinson's disease (PD). In this report, BDD was treated by stopping levodopa. After 15 days without levodopa, a positive outcome was achieved. The patient no longer exhibited BDD at the six-month and one-year follow-ups.

Keywords: Belly dancer dyskinesia; Levodopa, drug-induced movement disorder; Parkinsonism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Iliceto G., Thompson P.D., Day B.L., Rothwell J.C., Lees A.J., Marsden C.D. Diaphragmatic flutter, the moving umbilicus syndrome, and “belly dancer’s” dyskinesia. Mov. Disord. 1990;5(1):15–22. doi: 10.1002/mds.870050105. - DOI - PubMed
    1. Olanow C.W., Obeso J.A., Stocchi F. Drug insight: continuous dopaminergic stimulation in the treatment of Parkinson’s disease. Nat. Clin. Pract. Neurol. 2006;2(7):382–392. doi: 10.1038/ncpneuro0222. - DOI - PubMed
    1. Carecchio M., Collini A., Comi C., Cantello R., Bhatia K.P., Monaco F. Levodopa-induced belly dancer’s dyskinesias in Parkinson’s disease: report of one case. Mov. Disord. 2010;25(11):1760–1762. doi: 10.1002/mds.23345. - DOI - PubMed
    1. Yeh J.Y., Tu K.Y., Tseng P.T., Lee Y., Lin P.Y. Acute onset of abdominal muscle dyskinesia (‘belly dancer syndrome’) from quetiapine exposure: a case report. Clin. Neuropharmacol. 2018;41(2):73–74. doi: 10.1097/WNF.0000000000000271. - DOI - PubMed
    1. Chen J.J., Ly A.V. Rasagiline: a second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson’s disease. Am. J. Health Syst. Pharm. 2006;63(10):915–928. doi: 10.2146/ajhp050395. - DOI - PubMed

Publication types

LinkOut - more resources